Oil futures drifted into negative territory Friday, but remained on track for weekly gains as concerns over supply appeared to take over the spotlight from longer-term worries over global economic growth and the outlook for crude demand. West Texas Intermediate crude for December delivery CLZ19, +0.07%  on the New YorkRead More →

Investment thesis: Biotechnology investors work on the assumption that news surrounding assets in clinical development impact company valuation significantly. Our analysis suggests that focusing on earlier events, such as Phase 2 and 3 data release, represents a stronger short-term, catalyst-based investment strategy in the biotechnology sector, relative to PDUFA events.Read More →

The world economy appears to be slowing, with some analysts warning that recession risk is rising. Judging by year-to-date equity performances for the planet’s main economic regions, however, suggests that the crowd isn’t particularly worried. Although markets have been volatile lately, looking through the noise reminds that across-the-board gains rollRead More →